MAP2K2, one of the core drivers of cancer, encodes mitogen-activated protein kinase kinase 2 (MEK2) which plays a key role in mitogenic growth factor signaling, and knockdown of MEK2 inhibits the invasive ability of PAAD cancer cells (48). This evidence concerns the gene MAP2K2 and pancreatic adenocarcinoma.